Skip to main content

Table 3 Rectal cancer-related HSUVs

From: Systematic review of health state utility values for economic evaluation of colorectal cancer

Valuation methods used

HSUVs reported

Reference

SG

Healthcare professionals; patients

Disease recurrence 0.69; 0.72

Surgical resection 0.69; 0.83

Pain and complications 0.50; 0.78

Miller [7]

EQ-5D

PRT + TME 0.70-0.86

Recurrent 0.67 (local) 0.70 (distant) 0.48 (local/distant)

TME 0.63-1.0

Recurrent 0.80 (local) 0.64 (distant) 0.45 (local/distant)

Van den Brink [27]a

EQ-5D

Mean EQ-5D (SD)

Baseline before TME 0.88 (0.15)

6 weeks after TME 0.85(0.18)

12 weeks after TME 0.87 (0.19)

26 weeks after TME 0.88 (0.17)

52 weeks after TME 0.86 (0.6)

Hompes [18]

  1. a Ranges of reported HSUVs
  2. HSUVs health state utility values, SD standard deviation, SG standard gamble, PRT preoperative radiotherapy, TME total mesorectal excision